Attached files

file filename
EX-99.1 - EXHIBIT - TEAM HEALTH HOLDINGS INC.a11-19x13final.htm
        




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549
________________
FORM 8-K
________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 19, 2013 (November 18, 2013)
________________
Team Health Holdings, Inc.
(Exact name of registrant as specified in its charter)
________________
Delaware 
(State or other jurisdiction
of incorporation)
001-34583 
(Commission File Number)
36-4276525 
(I.R.S. Employer
Identification No.)
265 Brookview Centre Way, Suite 400
Knoxville, Tennessee
 
(Address of principal executive offices)
 
37919
(Zip Code)
 
 
 
Registrant’s telephone number, including area code: (865) 693-1000
Not Applicable
Former name or former address, if changed since last report
________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


        

        

Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(d)    On November 18, 2013, the Board of Directors (the “Board”) of Team Health Holdings, Inc. (the “Company”) elected Joseph L. Herring and Neil M. Kurtz, MD. to the Board to fill vacancies currently on the Board, effective immediately. Mr. Herring will serve as a Class I director and Dr. Kurtz will serve as a Class III director. Mr. Herring and Dr. Kurtz have not been named to serve on any committee of the Board.
In accordance with the Company’s director compensation arrangements applicable to all non-employee directors (other than Neil P. Simpkins), each of Mr. Herring and Dr. Kurtz (i) will receive an annual cash retainer of $70,000 for serving as a director and (ii) received a grant of 336 restricted shares upon his appointment to the Board. The vesting terms of the restricted shares are consistent with those applicable to all other non-employee directors (other than Neil P. Simpkins). In addition, in connection with their appointment to the Board, each of Mr. Herring and Dr. Kurtz entered into the form director indemnification agreement with the Company.

A copy of the press release announcing the appointment of Mr. Herring and Dr. Kurtz to the Board is attached as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01
Financial Statements and Exhibits
(d) Exhibits
 
 
 
Exhibit No.
 
Description
 
 
 
Exhibit 99.1
 
Press release, dated as of November 18, 2013.



2
        
        

        



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TEAM HEALTH HOLDINGS, INC.


Date: November 19, 2013    By:    /s/ David P. Jones                
Name: David P. Jones
Title: Executive Vice President and
Chief Financial Officer

3